SLC18A2 and neuroendocrine carcinoma: VMAT2 and VMAT1 are reliable markers for differentiation of gastric endocrine hyperplasia and neoplasia from ECL and EC and potentially valuable markers in categorizing neuroendocrine cancer [113,114].